Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy vs Immediate Surgery in High-Risk UTUC
NCT07492225Phase 2Active, not recruiting
- Sponsor
- Changhai Hospital
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, cisplatin in upper tract urothelial carcinoma (UTUC), sponsored by Changhai Hospital. Started Aug 2025; status: active, not recruiting.
02
Drugs
gemcitabinecisplatin
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT07492225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07492225.